BioCentury
ARTICLE | Company News

Arbor Pharmaceuticals, Eisai sales and marketing update

December 24, 2012 8:00 AM UTC

Eisai divested U.S. rights to its Gliadel Wafer implants to Arbor. The biodegradable polymer implant containing carmustine is approved as an adjunct to surgery and radiation in patients with newly di...